These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32638047)

  • 1. Synergistic effects of pazopanib and hyperthermia against uterine leiomyosarcoma growth mediated by downregulation of histone acetyltransferase 1.
    Lin CY; Chao A; Wu RC; Lee LY; Ueng SH; Tsai CL; Lee YS; Peng MT; Yang LY; Huang HJ; Wang HS; Lai CH
    J Mol Med (Berl); 2020 Aug; 98(8):1175-1188. PubMed ID: 32638047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072.
    Benson C; Ray-Coquard I; Sleijfer S; Litière S; Blay JY; Le Cesne A; Papai Z; Judson I; Schöffski P; Chawla S; Gil T; Piperno-Neumann S; Marréaud S; Dewji MR; van der Graaf WTA
    Gynecol Oncol; 2016 Jul; 142(1):89-94. PubMed ID: 27012429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of Uterine Leiomyosarcoma with Long-Term Disease Control by Pazopanib.
    Nagamata S; Ebina Y; Yamano Y; Miyamoto T; Nishijima M; Yamada H
    Kobe J Med Sci; 2016 Jul; 62(2):E45-8. PubMed ID: 27578036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulatory function of miR-200c on inflammatory and cell-cycle associated genes in SK-LMS-1, a leiomyosarcoma cell line.
    Chuang TD; Ho M; Khorram O
    Reprod Sci; 2015 May; 22(5):563-71. PubMed ID: 25305131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper ions are novel therapeutic agents for uterine leiomyosarcoma.
    Kakuda M; Matsuzaki S; Ueda Y; Shiomi M; Matsuzaki S; Kimura T; Fujita M; Egawa-Takata T; Kobayashi E; Serada S; Yoshino K; Naka T; Kimura T
    Am J Obstet Gynecol; 2020 Jan; 222(1):64.e1-64.e16. PubMed ID: 31351063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic drug evaluation of pazopanib for the treatment of uterine leiomyosarcomas.
    Ferrero S; Leone Roberti Maggiore U; Aiello N; Barra F; Ditto A; Bogani G; Raspagliesi F; Lorusso D
    Expert Opin Drug Metab Toxicol; 2017 Aug; 13(8):881-889. PubMed ID: 28678537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour.
    Stacchiotti S; Tortoreto M; Baldi GG; Grignani G; Toss A; Badalamenti G; Cominetti D; Morosi C; Dei Tos AP; Festinese F; Fumagalli E; Provenzano S; Gronchi A; Pennacchioli E; Negri T; Dagrada GP; Spagnuolo RD; Pilotti S; Casali PG; Zaffaroni N
    Eur J Cancer; 2014 Nov; 50(17):3021-8. PubMed ID: 25269954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pazopanib, a novel multi-kinase inhibitor, shows potent antitumor activity in colon cancer through PUMA-mediated apoptosis.
    Zhang L; Wang H; Li W; Zhong J; Yu R; Huang X; Wang H; Tan Z; Wang J; Zhang Y
    Oncotarget; 2017 Jan; 8(2):3289-3303. PubMed ID: 27924057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pazopanib-induced regression of metastatic cardiac tumor from uterine leiomyosarcoma evaluated by cardiac computed tomography.
    Yoshihara S
    Ginekol Pol; 2024; 95(2):169-170. PubMed ID: 37642247
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of Aberrantly Overexpressed Polo-like Kinase 4 Is a Potential Effective Treatment for DNA Damage Repair-Deficient Uterine Leiomyosarcoma.
    Lee HHY; Chow KL; Wong HS; Chong TY; Wong AST; Cheng GHW; Ko JMK; Siu HC; Yeung MCF; Huen MSY; Tse KY; Bray MR; Mak TW; Leung SY; Ip PPC
    Clin Cancer Res; 2024 Sep; 30(17):3904-3918. PubMed ID: 38848043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (Pre-)clinical pharmacology and activity of pazopanib, a novel multikinase angiogenesis inhibitor.
    Hamberg P; Verweij J; Sleijfer S
    Oncologist; 2010; 15(6):539-47. PubMed ID: 20511320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HAT1 Coordinates Histone Production and Acetylation via H4 Promoter Binding.
    Gruber JJ; Geller B; Lipchik AM; Chen J; Salahudeen AA; Ram AN; Ford JM; Kuo CJ; Snyder MP
    Mol Cell; 2019 Aug; 75(4):711-724.e5. PubMed ID: 31278053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Pazopanib in patients with metastatic uterine sarcoma: A multi-institutional study.
    Sunar V; Korkmaz V; Akin S; Can Guven D; Arik Z; Ates O; Yilmaz M; Mutlu Meydanli M; Oksuzoglu B
    J BUON; 2019; 24(6):2327-2332. PubMed ID: 31983102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TOP2A copy number and TOP2A expression in uterine benign smooth muscle tumours and leiomyosarcoma.
    Baiocchi G; Poliseli FL; De Brot L; Mantoan H; Schiavon BN; Faloppa CC; Vassallo J; Soares FA; Cunha IW
    J Clin Pathol; 2016 Oct; 69(10):884-9. PubMed ID: 26994023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study
    Gelderblom H; Judson IR; Benson C; Merimsky O; Grignani G; Katz D; Freivogel KW; Stein D; Jobanputra M; Mungul A; Manson SC; Sanfilippo R
    Acta Oncol; 2017 Dec; 56(12):1769-1775. PubMed ID: 28723233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavokawain B, a novel, naturally occurring chalcone, exhibits robust apoptotic effects and induces G2/M arrest of a uterine leiomyosarcoma cell line.
    Eskander RN; Randall LM; Sakai T; Guo Y; Hoang B; Zi X
    J Obstet Gynaecol Res; 2012 Aug; 38(8):1086-94. PubMed ID: 22540374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpressed histone acetyltransferase 1 regulates cancer immunity by increasing programmed death-ligand 1 expression in pancreatic cancer.
    Fan P; Zhao J; Meng Z; Wu H; Wang B; Wu H; Jin X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):47. PubMed ID: 30709380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of fibroblast growth factor 2 in patients with uterine smooth muscle tumors: an immunohistochemical study.
    Bodner-Adler B; Mayerhofer K; Czerwenka K; Kimberger O; Koelbl H; Bodner K
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():62-67. PubMed ID: 27825029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic proapoptotic effects of the two tyrosine kinase inhibitors pazopanib and lapatinib on multiple carcinoma cell lines.
    Olaussen KA; Commo F; Tailler M; Lacroix L; Vitale I; Raza SQ; Richon C; Dessen P; Lazar V; Soria JC; Kroemer G
    Oncogene; 2009 Dec; 28(48):4249-60. PubMed ID: 19749798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone Acetyltransferase-Dependent Pathways Mediate Upregulation of NADPH Oxidase 5 in Human Macrophages under Inflammatory Conditions: A Potential Mechanism of Reactive Oxygen Species Overproduction in Atherosclerosis.
    Vlad ML; Manea SA; Lazar AG; Raicu M; Muresian H; Simionescu M; Manea A
    Oxid Med Cell Longev; 2019; 2019():3201062. PubMed ID: 31565149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.